Sigmapharm Laboratories, LLC
FDA Approved Drugs
Sigmapharm Laboratories, LLC
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 34
- Latest Approval Date Dec 10, 2020
- Data Source FDA
- First Approval Date Jan 30, 2009
Company Overview
Company
Sigmapharm Laboratories, LLC
Country
U.S.A
Website
Social Profiles
Company Snapshot
Sigmapharm Laboratories, LLC
Sigmapharm Laboratories, LLC 3375 Progress Drive Bensalem
U.S.A
www.sigmapharm.com/ akotrotsios@sigmapharm.com View on MapFDA Approved Drug Records ( 34 records )
Drug Name
ACITRETIN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2015-05-22
Active Ingredient
ACITRETIN
Application Number
204633
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2015-05-22
Regulatory Status
RX
Drug Name
ACITRETIN
Product Number
2
Dosage Form
-
Strength
17.5MG
Approval Date
2015-05-22
Active Ingredient
ACITRETIN
Application Number
204633
Product Number
2
Dosage Form
-
Strength
17.5MG
Approval Date
2015-05-22
Regulatory Status
RX
Drug Name
ACITRETIN
Product Number
3
Dosage Form
-
Strength
22.5MG
Approval Date
2015-05-22
Active Ingredient
ACITRETIN
Application Number
204633
Product Number
3
Dosage Form
-
Strength
22.5MG
Approval Date
2015-05-22
Regulatory Status
RX
Drug Name
ACITRETIN
Product Number
4
Dosage Form
-
Strength
25MG
Approval Date
2015-05-22
Active Ingredient
ACITRETIN
Application Number
204633
Product Number
4
Dosage Form
-
Strength
25MG
Approval Date
2015-05-22
Regulatory Status
RX
Drug Name
ADEFOVIR DIPIVOXIL
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2013-08-29
Active Ingredient
ADEFOVIR DIPIVOXIL
Application Number
202051
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2013-08-29
Regulatory Status
RX
Drug Name
AMBRISENTAN
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-04-10
Active Ingredient
AMBRISENTAN
Application Number
208354
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2019-04-10
Regulatory Status
RX
Drug Name
AMBRISENTAN
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2019-04-10
Active Ingredient
AMBRISENTAN
Application Number
208354
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2019-04-10
Regulatory Status
RX
Drug Name
AMILORIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2009-01-30
Active Ingredient
AMILORIDE HYDROCHLORIDE
Application Number
79133
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2009-01-30
Regulatory Status
RX
Drug Name
APIXABAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
-
Active Ingredient
APIXABAN
Application Number
210053
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
APIXABAN
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
-
Active Ingredient
APIXABAN
Application Number
210053
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ASENAPINE MALEATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2020-12-10
Active Ingredient
ASENAPINE MALEATE
Application Number
206107
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2020-12-10
Regulatory Status
RX
Drug Name
ASENAPINE MALEATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-12-10
Active Ingredient
ASENAPINE MALEATE
Application Number
206107
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-12-10
Regulatory Status
RX
Drug Name
DISULFIRAM
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2011-03-28
Active Ingredient
DISULFIRAM
Application Number
91619
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2011-03-28
Regulatory Status
RX
Drug Name
DISULFIRAM
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2011-03-28
Active Ingredient
DISULFIRAM
Application Number
91619
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2011-03-28
Regulatory Status
RX
Drug Name
DOFETILIDE
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
2018-03-26
Active Ingredient
DOFETILIDE
Application Number
207746
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
2018-03-26
Regulatory Status
RX
Drug Name
DOFETILIDE
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
2018-03-26
Active Ingredient
DOFETILIDE
Application Number
207746
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
2018-03-26
Regulatory Status
RX
Drug Name
DOFETILIDE
Product Number
3
Dosage Form
-
Strength
0.5MG
Approval Date
2018-03-26
Active Ingredient
DOFETILIDE
Application Number
207746
Product Number
3
Dosage Form
-
Strength
0.5MG
Approval Date
2018-03-26
Regulatory Status
RX
Drug Name
ERGOCALCIFEROL
Product Number
1
Dosage Form
-
Strength
50,000 IU
Approval Date
2010-07-14
Active Ingredient
ERGOCALCIFEROL
Application Number
91004
Product Number
1
Dosage Form
-
Strength
50,000 IU
Approval Date
2010-07-14
Regulatory Status
Discontinued
Drug Name
FLUCYTOSINE
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2011-06-28
Active Ingredient
FLUCYTOSINE
Application Number
201566
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
2011-06-28
Regulatory Status
RX
Drug Name
FLUCYTOSINE
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2011-06-28
Active Ingredient
FLUCYTOSINE
Application Number
201566
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2011-06-28
Regulatory Status
RX
Drug Name
GRISEOFULVIN
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2012-10-22
Active Ingredient
GRISEOFULVIN, MICROSIZE
Application Number
202482
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2012-10-22
Regulatory Status
RX
Drug Name
GRISEOFULVIN,ULTRAMICROSIZE
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2012-10-22
Active Ingredient
GRISEOFULVIN, ULTRAMICROSIZE
Application Number
202545
Product Number
1
Dosage Form
-
Strength
125MG
Approval Date
2012-10-22
Regulatory Status
RX
Drug Name
GRISEOFULVIN,ULTRAMICROSIZE
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2012-10-22
Active Ingredient
GRISEOFULVIN, ULTRAMICROSIZE
Application Number
202545
Product Number
2
Dosage Form
-
Strength
250MG
Approval Date
2012-10-22
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 0.005MG BASE
Approval Date
2012-11-29
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
200295
Product Number
1
Dosage Form
-
Strength
EQ 0.005MG BASE
Approval Date
2012-11-29
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE
Approval Date
2012-11-29
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
200295
Product Number
2
Dosage Form
-
Strength
EQ 0.025MG BASE
Approval Date
2012-11-29
Regulatory Status
RX
Drug Name
LIOTHYRONINE SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 0.05MG BASE
Approval Date
2012-11-29
Active Ingredient
LIOTHYRONINE SODIUM
Application Number
200295
Product Number
3
Dosage Form
-
Strength
EQ 0.05MG BASE
Approval Date
2012-11-29
Regulatory Status
RX
Drug Name
NITROGLYCERIN
Product Number
1
Dosage Form
-
Strength
0.3MG
Approval Date
2018-05-07
Active Ingredient
NITROGLYCERIN
Application Number
207745
Product Number
1
Dosage Form
-
Strength
0.3MG
Approval Date
2018-05-07
Regulatory Status
Discontinued
Drug Name
NITROGLYCERIN
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2018-05-07
Active Ingredient
NITROGLYCERIN
Application Number
207745
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2018-05-07
Regulatory Status
Discontinued
Drug Name
NITROGLYCERIN
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2018-05-07
Active Ingredient
NITROGLYCERIN
Application Number
207745
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2018-05-07
Regulatory Status
Discontinued
Drug Name
POTASSIUM CHLORIDE
Product Number
1
Dosage Form
-
Strength
8MEQ
Approval Date
2016-08-19
Active Ingredient
POTASSIUM CHLORIDE
Application Number
207528
Product Number
1
Dosage Form
-
Strength
8MEQ
Approval Date
2016-08-19
Regulatory Status
Discontinued
Drug Name
POTASSIUM CHLORIDE
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2016-08-19
Active Ingredient
POTASSIUM CHLORIDE
Application Number
207528
Product Number
2
Dosage Form
-
Strength
10MEQ
Approval Date
2016-08-19
Regulatory Status
Discontinued
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-05-03
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
90462
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2010-05-03
Regulatory Status
RX
Drug Name
PROTRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2010-05-03
Active Ingredient
PROTRIPTYLINE HYDROCHLORIDE
Application Number
90462
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2010-05-03
Regulatory Status
RX
Drug Name
SODIUM PHENYLBUTYRATE
Product Number
1
Dosage Form
-
Strength
3GM/TEASPOONFUL
Approval Date
2013-03-22
Active Ingredient
SODIUM PHENYLBUTYRATE
Application Number
202819
Product Number
1
Dosage Form
-
Strength
3GM/TEASPOONFUL
Approval Date
2013-03-22
Regulatory Status
Discontinued
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
34 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
34 total- RX
- Unclassified
- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ACITRETIN
Application Number
204633
Product Number
1
Active Ingredient
ACITRETIN
Dosage Form
-
Strength
10MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.